Develop with confidence. Validate with precision. Deliver with regulatory readiness.

Trusted Bioanalytical Method Development for Complex Drug Programs

Alturas Analytics offers GLP-compliant bioanalytical method development and validation services for small molecules, together with protein, peptide, and other complex modalities. Our team of scientists uses their extensive expertise to create methods that address unique problems associated with your analytical compound and biological matrix, while maintaining regulatory standards.

The development of accurate, precise, and reproducible assays for global regulatory compliance is standard regardless of whether is supports a preclinical IND enabling study or later stage clinical programs. Our method development and validation process results in assays which meet global regulatory expectations through precise and reproducible testing. The development of each method includes thorough documentation and data integrity to achieve audit-readiness.


Full-Service Method Development and Validation

The team at Alturas Analytics delivers method development alongside method validation services under one roof. We direct every phase of the process from initial feasibility testing through final regulatory documentation with consistent procedures, transparent operations, and swift execution. The scientific team at Alturas work together with QA personnel to develop methods which address your drug development and research goals.

Our services include:

  • Custom method development aligned with FDA and EMA guidelines
  • Accuracy and precision assessments across QC levels
  • Full and partial method validation under GLP
  • Bridging studies and method transfer support

Your development goals depend heavily on both timeline adherence and data quality standards. Our team delivers reliable results by combining proactive communication with detailed planning and responsive execution to meet regulatory standards.

Explore more: Bioanalytical Services »


Scientific Expertise Across Modalities and Matrices

The bioanalytical scientists at our organization have developed and validated hundreds of assays for different drug types and matrices.

We support:

  • Small molecules
  • Peptides, proteins and ADCs
  • Plasma, serum, cerebrospinal fluid (CSF), urine, and tissue homogenates

We start each project by performing a thorough analysis of your compound requirements and study specifications. Our team establishes a method that delivers specific results with high sensitivity and reproducibility, while adhering to all regulatory standards.

Related services: PK/TK Services » | LC-MS/MS Services »


Technology-Driven Accuracy and Precision

Alturas Analytics employs state-of-the-art LC-MS/MS, GC-MS, and HRMS equipment alongside validated software programs and established workflows to provide high-quality, regulatory-compliant results during every stage of development.

Our Core Capabilities

Capability Description
Assay Development & Optimization  Tailored methods for small molecules and biologics
Matrix Selection & Characterization Evaluation and handling of plasma, serum, tissue homogenates, and other matrices
Method Validation (ICH M10 Guidelines) Full GLP-compliant protocols for global submissions
Accuracy and Precision Studies Inter- and intra-assay reproducibility assessments
Selectivity and Sensitivity Testing Measurement of potential interference and matrix effects
Stability Assessments Bench-top, freeze/thaw, and long-term sample stability testing
Partial Validations & Bridging Studies Assay updates or alternative matrix validations
Platform Transfers & Cross-Validation Full support for method transfers and equivalency studies
Regulatory Documentation & Audit Readiness Comprehensive reports aligned with agency expectations

Designed for Regulatory Success

The validation protocols at Alturas Analytics exist to fulfill all requirements set by the global regulatory authorities. The Quality Assurance team maintains close contact with scientific staff to ensure that methods remain defensible and have complete documentation and tracing capabilities.

Your final package includes:

  • Regulatory-ready validation reports
  • Long-term stability data

We don’t just prepare for audit we help you feel ready to stand behind your data when it counts most. Quality Assurance »


What Sets Alturas Analytics Apart

Alturas Analytics stands out as the preferred choice of sponsors because we deliver both data and confidence throughout all stages of development.

  • Experienced Scientific Leadership – Our team includes PhD-level scientists and principal investigators who bring decades of bioanalytical experience to every project
  • Regulatory Fluency – Deep working knowledge of global regulatory guidelines for method validation and transfer
  • Flexible and Scalable – We provide reliable results while managing changing study plans
  • Specialized Matrix Expertise – Proven success with challenging matrices like CSF and tissue homogenates
  • Transparent Collaboration – Consistent communication and problem-solving from kickoff through submission

Meet the team behind the science: Our Leadership »


Frequently Asked Questions


The time to complete the method development and validation process is based on the complexity of the work. Each project begins with a detailed project schedule and set of milestones.

Yes. We support method transfer and cross-validation projects, which include both bridging studies and regulatory comparison procedures.

Absolutely. Our laboratory specializes in working with various biological samples, which includes processing limited quantities of cerebrospinal fluid (CSF) and synovial fluid and tissue homogenates.

Yes. Method development and validation services are conducted under Good Laboratory Practice (GLP) conditions with complete quality assurance (QA) documentation and oversight.


Let’s Build a Better Method

Does your organization need a method development or validation service to pass regulatory reviews while supporting clinical and preclinical operations?

Our team is ready to collaborate. Let’s discuss your compound, matrix, and submission goals to create a plan that helps you achieve your objectives.

Schedule a Consultation

Contact Us
Explore Technical Resources

Related Services:

Bioanalytical Services
LC-MS/MS Services
PK/TK Services
Quality Assurance
Leadership Team

Speak with an Expert

Jennifer Zimmer, PhD

Chief Operating Officer

Dr. Jennifer Zimmer is the Chief Operating Officer at Alturas Analytics, Inc. and has worked in the field of bioanalysis for over 20 years. Dr. Zimmer is responsible for the overall operation of the Alturas Analytics laboratory, ensuring client deliverables are met while working laterally with Alturas QAU to maintain laboratory compliance with all procedures and regulations.

"*" indicates required fields

Let us know how we can help. Please be specific.